CN Patent

CN113200966B — 一种呋喹替尼衍生物、药物组合物和用途

Assigned to Shenzhen University · Expires 2022-07-22 · 4y expired

What this patent protects

本发明涉及一种呋喹替尼衍生物、药物组合物和用途，所述呋喹替尼衍生物的通式如式所示，其中，R 1 、R 2 、R 3 、R 4 、R 5 、R 6 、R 7 、R 8 、R 9 、R 10 、R 11 、R 12 、R 13 、R 14 、R 15 、R 16 、R 17 、R 18 、R 19 具有在说明书中给出的含义。本发明所提供的氘代呋喹替尼衍生物，具备显著更好的药效学/药代动力学特性，作为药用有效组分可以提高药物疗效，减少药物毒副作用。

USPTO Abstract

本发明涉及一种呋喹替尼衍生物、药物组合物和用途，所述呋喹替尼衍生物的通式如式所示，其中，R 1 、R 2 、R 3 、R 4 、R 5 、R 6 、R 7 、R 8 、R 9 、R 10 、R 11 、R 12 、R 13 、R 14 、R 15 、R 16 、R 17 、R 18 、R 19 具有在说明书中给出的含义。本发明所提供的氘代呋喹替尼衍生物，具备显著更好的药效学/药代动力学特性，作为药用有效组分可以提高药物疗效，减少药物毒副作用。

Drugs covered by this patent

Patent Metadata

Patent number: CN113200966B
Jurisdiction: CN
Classification: —
Expires: 2022-07-22
Drug substance claim: No
Drug product claim: No
Assignee: Shenzhen University
Source: FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.